Perioperative colloids: From theory to practice

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Pinillos, J. L. Jover
  • Macaya, M. Basora
  • Ripolles-Melchor, J.
  • Pitarch, J. V. Llau
  • Soler, M. J. Colomina
  • Nombre Grp Invest Estudio Fluid

Grupos

Abstract

Introduction: Fluid administration is the cornerstone in hypovolemic patient's reanimation. Clinical guidelines restrict colloid administration favouring crystalloids. Currently, we don't know exactly which is the daily clinical practice during the perioperative period. The objective of this study is to describe perioperative use of colloids analysing possible reasons aiming to use them.Material and Methods: Prospective, cross-section, national, multicentre observational study. Fluid Day sub-study. We enrolled all patient's older than 18 years old who underwent surgery during the 24 h of the 2-days study (February, 2019, 18th and 20th). We registered demographic data, comorbidities, anaesthetic and surgical procedure data, fluids administered, periopera-tive bleeding and monitoring type used during the perioperative period. Results: A total of 5928 cases were analysed and 542 patients (9.1%) received any type of colloids, being hydroxiethyl-starch the most frequently used (5.1%). Patients receiving colloids suffered more longing surgery (150 [90-255] vs. 75 [45-120] min), were urgently operated (13.7 vs. 7.5%) and were more frequent classified as high risk (22 vs. 4.8%). Their recovery was mostly in critical care units (45.1 vs.15.8%). Patients with bleeding less than 500 mL received colloids in a percentage of 5.9 versus 45.9% when this figure was overcome. Patients who received colloids were anaemic more frequently: 29.4 vs. 16.3%. Colloids administration had a higher risk for transfusion (OR 15.7). Advanced monitoring also increased the risk for receiving colloids (OR 9.43).Conclusions: In our environment with routine clinical practice, colloids administration is limited and close linked to perioperative bleeding.(c) 2022 Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor. Published by Elsevier Espana, S.L.U. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0034-9356, 2340-3284

Revista espanola de anestesiologia y reanimacion  ELSEVIER SCIENCE BV

Tipo:
Article
Páginas:
187-197
Factor de Impacto:
0,258 SCImago
Cuartil:
Q3 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Fluid therapy; Colloids; Crystalloids; Balanced crystalloids; Perioperative bleeding; Anaemia

Proyectos asociados

ENSAYO DE FASE III, ALEATORIZADO, DOBLE CIEGO, MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE OCTAPLEX, UN CONCENTRADO DE COMPLEJO DE PROTROMBINA DE CUATRO FACTORES (CCP-4F), EN COMPARACIÓN CON EL CCP-4F BERIPLEX® P/N (KCENTRA), PARA LA REVERSIÓ N DE LA ANTICOAGULACIÓN INDUCIDA POR ANTAGONISTAS DE LA VITAMINA K EN PACIENTES QUE REQUIEREN UNA INTERVENCIÓN QUIRÚRGICA DE URGENCIA Y QUE TIENEN UN RIESGO SIGNIFICATIVO DE HEMORRAGIA.

Investigador Principal: MARÍA AZUCENA PAJARES MONCHO

LEX-209 . 2017

FLUID DAY.

Investigador Principal: SALOMÉ MATOSES JAÉN

SED-HEA-2018-01 . 2019

ESTUDIO OBSERVACIONAL PROSPECTIVO ACERCA DEL MANEJO PERIOPERATORIO / PERIPROCEDIMIENTO DE LOS FÁRMACOS ANTITROMBÓTICOS EN EL “MUNDO REAL”: REGISTRO REQXAA.

Investigador Principal: RAQUEL FERRANDIS COMES

SEC-API-2019-01 . 2021

BIOMARKER- GUIDED INTERVENTION TO PREVENT ACUTE KIDNEY INJURY AFTER MAJOR NON-CARDIAC SURGERY THE PROSPECTIVE MULTICENTER RANDOMIZED CONTROLLED INTERVENTIONAL TRIAL. ACRONYM BIGPAK-2.

Investigador Principal: MARÍA ÁNGELES FERRE COLOMER

07-AnIt-20 . 2023

Descripción y evaluación del incremento de los niveles de fibrinógeno mediante test viscoelástico tras el empleo de concentrado de fibrinógeno.

Investigador Principal: MARÍA CATALÁN FERNÁNDEZ

INFIBRI-01-MCF-21 . 2021

Estudio de la coagulopatía adquirida del paciente quemado: Relación con la superficie corporal quemada y el tratamiento aplicado.

Investigador Principal: RAQUEL FERRANDIS COMES

TROMBURNT . PROPIO GRUPO . 2023

Cita

Compartir